FOLH1 and prostate cancer: In our study, the sensitivity and specificity of 18F-DCFPyL PSMA PET for the diagnosis of prostate cancer are 0.92 (95% CI: 0.85–0.96) and 0.59 (95% CI: 0.08–0.96), respectively.